A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1950
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes ; volume:81 ; number:9 ; day:8 ; month:5 ; year:2021 ; pages:1003-1030 ; date:6.2021
Drugs ; 81, Heft 9 (8.5.2021), 1003-1030, 6.2021
- Creator
-
Andersen, Andreas
Knop, Filip Krag
Vilsbøll, Tina
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40265-021-01499-w
- URN
-
urn:nbn:de:101:1-2021100820561741179545
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Andersen, Andreas
- Knop, Filip Krag
- Vilsbøll, Tina
- SpringerLink (Online service)
Other Objects (12)
Oral Semaglutide: Dosage in Special Situations
A Review on the Efficacy and Safety of Oral Semaglutide
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials
Semaglutide
Advances in GLP-1 treatment: focus on oral semaglutide
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviews
The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes
Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin, and Metformin in Healthy Subjects
Design of self-emulsifying oral delivery systems for semaglutide: reverse micelles versus hydrophobic ion pairs
Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS)
Oral Semaglutide: Dosage in Special Situations
A Review on the Efficacy and Safety of Oral Semaglutide
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials
Semaglutide
Advances in GLP-1 treatment: focus on oral semaglutide
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviews
The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes
Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin, and Metformin in Healthy Subjects
Design of self-emulsifying oral delivery systems for semaglutide: reverse micelles versus hydrophobic ion pairs
Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS)
Oral Semaglutide: Dosage in Special Situations
A Review on the Efficacy and Safety of Oral Semaglutide
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials
Semaglutide
Advances in GLP-1 treatment: focus on oral semaglutide
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviews
The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes
Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin, and Metformin in Healthy Subjects
Design of self-emulsifying oral delivery systems for semaglutide: reverse micelles versus hydrophobic ion pairs